$CMPS - Fundamentals are a lot more speculative but the TA looks really good. Long term breaking out and one analyst even has $70+ targets. This is a huge gamble as it's non revenue BUT if they get FDA approval or are able to go to commercial market and the results are good this quickly becomes a monster of a company. There could be a lot of push back by big pharma and there's a lot of risks on top of scheduling the drugs. They've got 500 million to work with in cash, cash burn much slower, and it seems like they are positioned well to have a semi productive 2026/2027. Another Trump tweet or White House pushing more for rescheduling could obviously cause more hype. Plan: 1% position on the breakout in case it never comes lower. Next play would be a 2% buy if we get way lower in the green and sit on it long term. The 3rd buy would be on momentum out of the buy zone or confirmation that it's got approval or massive insider buying/news shows up.

Published Jun 01, 2026Updated Jun 01, 20263 min read

COMPASS Pathways plc

1 Jun

OPENLONG

Invested Capital

Buying Price

14.54$

Current Price

13.27$

ROI

-8.73%

$CMPS - Fundamentals are a lot more speculative but the TA looks really good. Long term breaking out and one analyst even has $70+ targets. This is a huge gamble as it's non revenue BUT if they get FDA approval or are able to go to commercial market and the results are good this quickly becomes a monster of a company. There could be a lot of push back by big pharma and there's a lot of risks on top of scheduling the drugs. They've got 500 million to work with in cash, cash burn much slower, and it seems like they are positioned well to have a semi productive 2026/2027. Another Trump tweet or White House pushing more for rescheduling could obviously cause more hype. Plan: 1% position on the breakout in case it never comes lower. Next play would be a 2% buy if we get way lower in the green and sit on it long term. The 3rd buy would be on momentum out of the buy zone or confirmation that it's got approval or massive insider buying/news shows up.